{
  "cik": 1650648,
  "cik_padded": "0001650648",
  "entityName": "4D Molecular Therapeutics, Inc.",
  "fiscal_years": [
    {
      "accn": "0001193125-26-114075",
      "filed": "2026-03-18",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 536000.0,
        "cash": 60241000.0,
        "eps_diluted": -2.42,
        "free_cash_flow": -109618000.0,
        "net_income": -140109000.0,
        "operating_cash_flow": -109082000.0,
        "operating_income": -159547000.0,
        "revenue": 85209000.0,
        "stockholders_equity": 505664000.0,
        "total_assets": 566711000.0,
        "total_liabilities": 61047000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.12072641121377041,
        "revenue_growth_yoy": 2301.945945945946,
        "roa_avg2y": -0.24861968157076378,
        "roa_period_end": -0.24723183421532316,
        "roe_avg2y": -0.2757318429157606,
        "roe_period_end": -0.27707924629793695
      }
    },
    {
      "accn": "0001193125-26-114075",
      "filed": "2026-03-18",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 3786000.0,
        "cash": 149336000.0,
        "eps_diluted": -2.98,
        "free_cash_flow": -138371000.0,
        "net_income": -160868000.0,
        "operating_cash_flow": -134585000.0,
        "operating_income": -187841000.0,
        "revenue": 37000.0,
        "stockholders_equity": 510606000.0,
        "total_assets": 560384000.0,
        "total_liabilities": 49778000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.097488082787903,
        "revenue_growth_yoy": -0.998214544226222,
        "roa_avg2y": -0.3573752464524729,
        "roa_period_end": -0.2870674394700777,
        "roe_avg2y": -0.39311124279875614,
        "roe_period_end": -0.3150530937748479
      }
    },
    {
      "accn": "0001193125-26-114075",
      "filed": "2026-03-18",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 2771000.0,
        "cash": 249108000.0,
        "eps_diluted": -2.58,
        "free_cash_flow": -78563000.0,
        "net_income": -100837000.0,
        "operating_cash_flow": -75792000.0,
        "operating_income": -112867000.0,
        "revenue": 20723000.0,
        "stockholders_equity": 307829000.0,
        "total_assets": 339891000.0,
        "total_liabilities": 32062000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.1041552290394992,
        "revenue_growth_yoy": 5.622882710131032,
        "roa_avg2y": -0.3351530652095517,
        "roa_period_end": -0.29667452212621104,
        "roe_avg2y": -0.3740480668291398,
        "roe_period_end": -0.3275747249284505
      }
    },
    {
      "accn": "0000950170-25-030056",
      "filed": "2025-02-28",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 11536000.0,
        "cash": 52351000.0,
        "eps_diluted": -3.32,
        "free_cash_flow": -98221000.0,
        "net_income": -107494000.0,
        "operating_cash_flow": -86685000.0,
        "operating_income": -110032000.0,
        "revenue": 3129000.0,
        "stockholders_equity": 231337000.0,
        "total_assets": 261846000.0,
        "total_liabilities": 30509000.0
      },
      "period_end": "2022-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.13188119496665038,
        "revenue_growth_yoy": -0.8265328750415789,
        "roa_avg2y": -0.34938480465049004,
        "roa_period_end": -0.4105237429634212,
        "roe_avg2y": -0.39057197462412163,
        "roe_period_end": -0.46466410474761927
      }
    },
    {
      "accn": "0000950170-24-023183",
      "filed": "2024-02-29",
      "fiscal_year": 2021,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 9110000.0,
        "cash": 153001000.0,
        "eps_diluted": -2.57,
        "free_cash_flow": -78244000.0,
        "net_income": -71317000.0,
        "operating_cash_flow": -69134000.0,
        "operating_income": -71333000.0,
        "revenue": 18038000.0,
        "stockholders_equity": 319107000.0,
        "total_assets": 353487000.0,
        "total_liabilities": 34380000.0
      },
      "period_end": "2021-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.1077381567938027,
        "revenue_growth_yoy": 0.32515427563914195,
        "roa_avg2y": -0.22223434057630045,
        "roa_period_end": -0.20175282259319297,
        "roe_avg2y": -0.24784619822274429,
        "roe_period_end": -0.22348929982733065
      }
    },
    {
      "accn": "0000950170-23-008142",
      "filed": "2023-03-15",
      "fiscal_year": 2020,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 1000000.0,
        "cash": 276726000.0,
        "free_cash_flow": -51909000.0,
        "net_income": -56693000.0,
        "operating_cash_flow": -50909000.0,
        "operating_income": -56664000.0,
        "revenue": 13612000.0,
        "stockholders_equity": 256387000.0,
        "total_assets": 288331000.0,
        "total_liabilities": 31944000.0
      },
      "period_end": "2020-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.12459290057608224,
        "revenue_growth_yoy": 0.9484683653020326,
        "roa_avg2y": -0.3271709491725939,
        "roa_period_end": -0.1966247125699283,
        "roe_avg2y": -0.6181869728542065,
        "roe_period_end": -0.22112275583395413
      }
    },
    {
      "accn": "0000950170-22-004794",
      "filed": "2022-03-28",
      "fiscal_year": 2019,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 3203000.0,
        "cash": 49652000.0,
        "free_cash_flow": -39914000.0,
        "net_income": -49306000.0,
        "operating_cash_flow": -36711000.0,
        "operating_income": -50764000.0,
        "revenue": 6986000.0,
        "stockholders_equity": -72970000.0,
        "total_assets": 58234000.0,
        "total_liabilities": 28224000.0
      },
      "period_end": "2019-12-31",
      "ratio_units": {
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roa_period_end": -0.8466875021465124,
        "roe_avg2y": 0.9806577364082063
      }
    },
    {
      "accn": "0001564590-21-015502",
      "filed": "2021-03-25",
      "fiscal_year": 2018,
      "form": "10-K",
      "fundamental_units": {
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "stockholders_equity": -27587000.0
      },
      "period_end": "2018-12-31",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0001193125-26-114075",
    "filed": "2026-03-18",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2836",
  "sic_description": "Biological Products, (No Diagnostic Substances)",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001650648.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001650648.json"
  },
  "ticker": "FDMT"
}